Breast Neoplasms: all 12,820 studies
Page 12 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Ways of Retaining the Inframammary Fold in Implant-based Breast SurgeryRecruitingNCT06931548Not applicable
- Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in RussiaRecruitingNCT06930859
- JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First YearRecruitingNCT06930521Not applicable
- Improvement in Breast Skin Sensibility After Breast Reconstruction: a Comparison of 3 Surgical TechniquesRecruitingNCT06930378Not applicable
- Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 InhibitorsNot yet recruitingNCT06929325Phase 3
- Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in KoreaRecruitingNCT06928818
- Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)RecruitingNCT06928701Not applicable
- Breast Cancer Implementation Science Study With Educational InterventionRecruitingNCT06927895Not applicable
- CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREARecruitingNCT06927648
- SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BCRecruitingNCT06927180Phase 2
- From Exclusion to Inclusion: Analysing Follow-up Discontinuity in Breast CancerRecruitingNCT06927102
- A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)RecruitingNCT06926868Phase 2/3
- Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With ChemotherapyRecruitingNCT06926543Phase 3
- Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse PopulationsNot yet recruitingNCT06926530
- Early Phase Study of KESONOTIDE™in Participants With Solid TumoursRecruitingNCT06926075Phase 1/2
- Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)RecruitingNCT06925984Not applicable
- Exercise to Improve Neurovascular Function in Breast Cancer SurvivorsNot yet recruitingNCT06925529Not applicable
- Video-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer SurvivorsEnrolling by invitationNCT06924788Not applicable
- Implementing Polygenic Risk Scores for Breast Cancer Prevention: a Feasibility StudyRecruitingNCT06922708Not applicable
- Viscum Album for TNBC on Adjuvant PembrolizumabRecruitingNCT06920810Phase 4
- TRACE4BUS for BI-RADS ClassificationNot yet recruitingNCT06920108
- Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast CancerRecruitingNCT06918262
- Timing of Specific Exercise Therapy After Breast Cancer Surgery: Early Versus Delayed InitiationRecruitingNCT06918184Not applicable
- Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast CancerRecruitingNCT06916637
- Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast CancerRecruitingNCT06916338
- CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast CancerRecruitingNCT06915168Not applicable
- Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast CancerRecruitingNCT06914440Phase 2
- Long-Term Multidisciplinary Physiotherapy for Breast Cancer Survivors: A Randomized Controlled TrialRecruitingNCT06913244Not applicable
- Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer TreatmentRecruitingNCT06911970Not applicable
- Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast CancerRecruitingNCT06911528Not applicable
- Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung CancerRecruitingNCT06910761Phase 2
- IDOV-Immune for Advanced Solid TumorsRecruitingNCT06910657Phase 1
- Evaluation of the Feasibility of a Study Comparing Local Anesthesia and General Anesthesia in Conservative Surgery for Breast CancerNot yet recruitingNCT06910280Not applicable
- Al18F-HER2-BCH PET in Breast Patients Treated With ADC TherapyRecruitingNCT06909604Not applicable
- Accelerated Partial Breast Irradiation Using External Beam Volumetric Modulated Arc Therapy (VMAT): a Randomised Non-inferiority Trial of 30 Gy Versus 26 Gy in Five Fractions Investigating Patient-reported OutcomesNot yet recruitingNCT06909032Not applicable
- Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response EvaluationRecruitingNCT06908291Not applicable
- Study of Lipid Mediators in Chronic Postoperative Pain - LICPRecruitingNCT06907810Not applicable
- Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.RecruitingNCT06906601
- Scarless Advanced Breast Extended Oncoplasty: The ScarABEO StudyRecruitingNCT06906237
- Topical Diclofenac for Prevention of Radiation-induced DermatitisRecruitingNCT06905561Not applicable
- Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world PracticeRecruitingNCT06905301
- Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate CancerRecruitingNCT06904625Not applicable
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenRecruitingNCT06904365
- Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisionsRecruitingNCT06903468Not applicable
- Using LUminoMark vs Coventional Practice for Targeted Axillary SurgeryNot yet recruitingNCT06903429Not applicable
- Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and UltrasoundNot yet recruitingNCT06902935
- Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)RecruitingNCT06902311Phase 2
- Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant RadiotherapyRecruitingNCT06902051Not applicable
- Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast CancerRecruitingNCT06900647Phase 1
- Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer PatientsRecruitingNCT06900374Not applicable
- EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II TrialRecruitingNCT06897488Phase 2
- SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast CancersRecruitingNCT06896474Not applicable
- PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and SurvivalRecruitingNCT06896162Not applicable
- EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly PhaseRecruitingNCT06894173
- The Effect of the Quran on Quality of Life and Quality of Sleep in Breast CancerNot yet recruitingNCT06893770Not applicable
- Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer PatientsRecruitingNCT06892093Not applicable
- 21-gene in Elder Breast Cancer Patients With Lymph Node MetastasisRecruitingNCT06891651
- Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm StudyEnrolling by invitationNCT06890871Phase 1/2
- Impact of PErioperative Nutrition Intervention on Bioimpedance Phase Angle (IPENIPA) In Breast Cancer PatientsRecruitingNCT06890221Not applicable
- Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast CancerRecruitingNCT06889688Phase 3
- Compare Analgesia Between MTP Block And ESPB in MRMRecruitingNCT06888258Not applicable
- Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)RecruitingNCT06885203Not applicable
- Ultrasound-guided Multilevel Erectorspinae Plane Block Versus Thoracic Epidural Analgesia for Prevention of Post Mastectomy Pain Syndrome for Breast Cancer PatientsRecruitingNCT06884852Not applicable
- The Effect of a Multi-modal Program on Fear of Cancer Recurrence in Breast Cancer PatientsNot yet recruitingNCT06883877Not applicable
- Application of Patient Blood Management in the Oncology Patient Affected by Breast CancerRecruitingNCT06883201
- Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer IINot yet recruitingNCT06882499Not applicable
- Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer SurgeryEnrolling by invitationNCT06881550Not applicable
- Circadian Rhythm Impact on TNBC Response to Neoadjuvant ImmunotherapyRecruitingNCT06880029Phase 1/2
- A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast CancerRecruitingNCT06878625Phase 2
- VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer PatientsRecruitingNCT06878547
- FDG-PET/CT vs. CT for Monitoring Metastatic Breast CancerRecruitingNCT06877949Not applicable
- Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast CancerRecruitingNCT06877416
- Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast CancerRecruitingNCT06876610
- Breast Cancer and Resilience in CoupleRecruitingNCT06875414
- Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant DiseaseRecruitingNCT06875128Phase 2
- Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)RecruitingNCT06874933Phase 2
- A Study to Learn More About Tukysa Once it is Out in the Korean MarketNot yet recruitingNCT06873191
- "Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"Not yet recruitingNCT06871501
- Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast CancerRecruitingNCT06869629Not applicable
- Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment CyclesNot yet recruitingNCT06868017Phase 4
- Breast Re-irradiation After Second Ipsilateral LumpectomyRecruitingNCT06867484Not applicable
- WashU DIEP Flap Video and Patient Understanding ImprovementRecruitingNCT06864754Not applicable
- Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast CancerRecruitingNCT06860815Phase 2
- Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast CancerRecruitingNCT06858449Not applicable
- Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.Not yet recruitingNCT06857747Not applicable
- Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III TrialEnrolling by invitationNCT06857305Phase 3
- REBECCA Real-world Early BrEast CanCer mAnagementRecruitingNCT06856343
- A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerRecruitingNCT06856200Not applicable
- Promoting Resilience in Women With Breast Cancer (PRISM -MBC)RecruitingNCT06855654Not applicable
- Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung CancerRecruitingNCT06855524Phase 2
- The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer.RecruitingNCT06851299Phase 2
- HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast CancerNot yet recruitingNCT06849492Phase 2
- Second-Look Ultrasound Post Contrast-Enhanced Mammography for Additional Lesions CharacterizationEnrolling by invitationNCT06846814
- JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast CancerRecruitingNCT06846437Phase 3
- Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary SyndromeEnrolling by invitationNCT06843096
- Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance?Enrolling by invitationNCT06843083
- PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast CancerNot yet recruitingNCT06842472Phase 2
- A Study of PHST001 in Advanced Solid TumorsRecruitingNCT06840886Phase 1
- CRYoablation for Small Tumors As Local Treatment - SIX TrialRecruitingNCT06839001Phase 3
- Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast CancerRecruitingNCT06837792Phase 2